Synthesis and in Vitro Evaluation of a Library of Modified Endomorphin 1 Peptides

Overview

Journal Bioorg Med Chem

Specialties Biochemistry
Chemistry

Date 2008 May 13

PMID 18468445

Citations 11

Authors

Yasuko Koda

Mark Del Borgo

Susanne T Wessling

Lawrence H Lazarus

Yoshio Okada

Istvan Toth

Joanne T Blanchfield

Affiliations

Soon will be listed here.

Abstract

Endomorphin 1 (Endo-1=Tyr-Pro-Trp-Phe-NH(2)), an endogenous opioid with high affinity and selectivity for mu-opioid receptors, mediates acute and neuropathic pain in rodents. To overcome metabolic instability and poor membrane permeability, the N- and C-termini of Endo-1 were modified by lipoamino acids (Laa) and/or sugars, and 2',6'-dimethyltyrosine (Dmt) replacement of Tyr. Analogues were assessed for mu-opioid receptor affinity, inhibition of cAMP accumulation, enzymatic stability, and permeability across Caco-2 cell monolayers. C-terminus modification decreased receptor affinity, while N-terminus C8-Laa improved stability and permeability with slight change in receptor affinity. Dmt provided a promising lead compound: [C8Laa-Dmt[1]]-Endo-1 is nine times more stable (t(1/2)=43.5min), >8-fold more permeable in Caco-2 cell monolayers, and exhibits 140-fold greater mu-opioid receptor affinity (K(imu)=0.08nM).

Citing Articles

Combining flavin photocatalysis with parallel synthesis: a general platform to optimize peptides with non-proteinogenic amino acids.

Immel J, Chilamari M, Bloom S Chem Sci. 2021; 12(29):10083-10091.

PMID: 34377401 PMC: 8317666. DOI: 10.1039/d1sc02562g.

Caco-2 Cell Permeability of Flavonoids and Saponins from : the Immortal Herb.

Ahmed I, Leach D, Wohlmuth H, De Voss J, Blanchfield J ACS Omega. 2020; 5(34):21561-21569.

PMID: 32905390 PMC: 7469392. DOI: 10.1021/acsomega.0c02180.

Food-Derived Hemorphins Cross Intestinal and Blood-Brain Barriers .

Domenger D, Cudennec B, Kouach M, Touche V, Landry C, Lesage J Front Endocrinol (Lausanne). 2018; 9:159.

PMID: 29692758 PMC: 5903475. DOI: 10.3389/fendo.2018.00159.

Design, synthesis and characterisation of mannosylated ovalbumin lipid core peptide self-adjuvanting vaccine delivery system.

Simerska P, Ziora Z, Fagan V, Goodwin D, Edrous F, Toth I Drug Deliv Transl Res. 2015; 4(3):246-55.

PMID: 25786879 DOI: 10.1007/s13346-013-0173-8.

Stability, permeability and growth-inhibitory properties of gonadotropin-releasing hormone liposaccharides.

Goodwin D, Varamini P, Simerska P, Toth I Pharm Res. 2014; 32(5):1570-84.

PMID: 25407542 DOI: 10.1007/s11095-014-1558-1.

References

Behrens I, Kamm W, Dantzig A, Kissel T . Variation of peptide transporter (PepT1 and HPT1) expression in Caco-2 cells as a function of cell origin. J Pharm Sci. 2004; 93(7):1743-54. DOI: 10.1002/jps.20062. View

Wong A, Ross B, Chan Y, Artursson P, Lazorova L, Jones A . Determination of transport in the Caco-2 cell assay of compounds varying in lipophilicity using LC-MS: enhanced transport of Leu-enkephalin analogues. Eur J Pharm Sci. 2002; 16(3):113-8. DOI: 10.1016/s0928-0987(02)00078-7. View

Balboni G, Guerrini R, Salvadori S, Negri L, Giannini E, Bryant S . Conversion of the potent delta-opioid agonist H-Dmt-Tic-NH-CH(2)-bid into delta-opioid antagonists by N(1)-benzimidazole alkylation(1). J Med Chem. 2005; 48(26):8112-4. PMC: 2597450. DOI: 10.1021/jm058259l. View

Cruciani G, Pastor M, Guba W . VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. Eur J Pharm Sci. 2000; 11 Suppl 2:S29-39. DOI: 10.1016/s0928-0987(00)00162-7. View

Lang V, Langguth P, Ottiger C, Wunderli-Allenspach H, Rognan D, Rothen-Rutishauser B . Structure-permeation relations of met-enkephalin peptide analogues on absorption and secretion mechanisms in Caco-2 monolayers. J Pharm Sci. 1997; 86(7):846-53. DOI: 10.1021/js960387x. View

Lohmann C, Huwel S, Galla H . Predicting blood-brain barrier permeability of drugs: evaluation of different in vitro assays. J Drug Target. 2002; 10(4):263-76. DOI: 10.1080/10611860290031903. View

van der Sandt I, Vos C, Nabulsi L, Voorwinden H, De Boer A, Breimer D . Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier. AIDS. 2001; 15(4):483-91. DOI: 10.1097/00002030-200103090-00007. View

BIRNBAUM S, Fu S, GREENSTEIN J . Resolution of the racemic alpha-amino derivatives of heptylic, caprylic, nonylic, decylic, and undecylic acids. J Biol Chem. 1953; 203(1):333-8. View

Li T, Fujita Y, Tsuda Y, Miyazaki A, Ambo A, Sasaki Y . Development of potent mu-opioid receptor ligands using unique tyrosine analogues of endomorphin-2. J Med Chem. 2005; 48(2):586-92. DOI: 10.1021/jm049384k. View

10.

Podlogar B, Paterlini M, Ferguson D, Leo G, Demeter D, Brown F . Conformational analysis of the endogenous mu-opioid agonist endomorphin-1 using NMR spectroscopy and molecular modeling. FEBS Lett. 1998; 439(1-2):13-20. DOI: 10.1016/s0014-5793(98)01202-2. View

11.

Przewlocka B, Mika J, Labuz D, Toth G, Przewlocki R . Spinal analgesic action of endomorphins in acute, inflammatory and neuropathic pain in rats. Eur J Pharmacol. 1999; 367(2-3):189-96. DOI: 10.1016/s0014-2999(98)00956-x. View

12.

In Y, Minoura K, Tomoo K, Sasaki Y, Lazarus L, Okada Y . Structural function of C-terminal amidation of endomorphin. Conformational comparison of mu-selective endomorphin-2 with its C-terminal free acid, studied by 1H-NMR spectroscopy, molecular calculation, and X-ray crystallography. FEBS J. 2005; 272(19):5079-97. DOI: 10.1111/j.1742-4658.2005.04919.x. View

13.

Alewood P, Alewood D, Miranda L, Love S, Meutermans W, Wilson D . Rapid in situ neutralization protocols for Boc and Fmoc solid-phase chemistries. Methods Enzymol. 1997; 289:14-29. DOI: 10.1016/s0076-6879(97)89041-6. View

14.

Artursson P, Karlsson J . Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem Biophys Res Commun. 1991; 175(3):880-5. DOI: 10.1016/0006-291x(91)91647-u. View

15.

Vojkovsky T . Detection of secondary amines on solid phase. Pept Res. 1995; 8(4):236-7. View

16.

He X, Sugawara M, Kobayashi M, Takekuma Y, Miyazaki K . An in vitro system for prediction of oral absorption of relatively water-soluble drugs and ester prodrugs. Int J Pharm. 2003; 263(1-2):35-44. DOI: 10.1016/s0378-5173(03)00343-0. View

17.

Hosoya K, Kim K, Lee V . Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers. Pharm Res. 1996; 13(6):885-90. DOI: 10.1023/a:1016005212640. View

18.

Blanchfield J, Toth I . Lipid, sugar and liposaccharide based delivery systems 2. Curr Med Chem. 2004; 11(17):2375-82. DOI: 10.2174/0929867043364621. View

19.

Zornoza T, Cano-Cebrian M, Nalda-Molina R, Guerri C, Granero L, Polache A . Assessment and modulation of acamprosate intestinal absorption: comparative studies using in situ, in vitro (CACO-2 cell monolayers) and in vivo models. Eur J Pharm Sci. 2004; 22(5):347-56. DOI: 10.1016/j.ejps.2004.04.004. View

20.

Lengyel I, Orosz G, Biyashev D, Kocsis L, Al-Khrasani M, Ronai A . Side chain modifications change the binding and agonist properties of endomorphin 2. Biochem Biophys Res Commun. 2002; 290(1):153-61. DOI: 10.1006/bbrc.2001.6136. View